健民集团: 健民集团2025年第一次临时股东大会决议公告

Meeting Overview - The shareholders' meeting of Jianmin Pharmaceutical Group Co., Ltd. was held on July 30, 2025, in Wuhan [1] - The meeting was attended by shareholders representing 41.6122% of the total shares [1] - The meeting was presided over by the vice chairman of the board, Mr. Xu Liang, and followed legal procedures as per the Company Law and Articles of Association [1] Voting Results - All non-cumulative voting proposals were approved with significant majority support, with votes in favor ranging from 91.0178% to 99.9309% across various proposals [1][2] - Specific voting results included: - Proposal 1: 58,116,051 votes in favor (91.0444%) [1] - Proposal 2: 63,775,260 votes in favor (99.9101%) [1] - Proposal 3: 63,576,660 votes in favor (99.5990%) [2] Legal Confirmation - The meeting was legally validated by lawyers Lin Ling and Chen Lin, confirming that the meeting's convening, attendance, and voting procedures complied with the Articles of Association [3]